Toronto-based Felix Health has secured $53 million in growth financing led by the Canadian Business Growth Fund (CBGF), with participation from BDC’s Women in Tech Venture Fund, BMO, Scotiabank, Whitecap Venture Partners, and H Venture Partners. The funding—an even mix of equity and debt—follows Felix’s recent profitability milestone and 80% year-over-year growth, reaching a $150-million annual run rate.
Founded in 2019, Felix offers personalized telehealth for over 20 conditions including mental health, menopause, and weight management. CEO Kyle Zien said the company plans to scale operations ahead of generic GLP-1 availability and invest in preventive “longevity” programs.
Want to know more? Check out the source code on BetaKit.